A monthly brief of partnerships, products, approvals and field reports across clinical AI, pharma and consumer health — sourced from the web, LinkedIn, Reddit and PubMed.
A user recounts a first AFib episode in São Paulo and how ChatGPT walked him through symptoms, ECG interpretation, and next steps — a real-world case study for consumer LLMs as a triage layer.
WHOOP raised $575M with Abbott joining major institutional and health-system investors, fueling its push to become a global AI-powered health platform.
Strategic partnership to combine Profluent's frontier AI platform with Lilly's genetic medicine capabilities — targeting kilobase-scale DNA editing across multiple diseases.
Multi-year, up-to-$1B partnership deploying Gemini Enterprise and agentic AI across Merck's R&D, manufacturing, commercial and corporate functions.
Fierce Healthcare reports on how cancer patients are blending Reddit peer communities with LLM-driven research to navigate diagnoses — and the trust questions this raises.
Strategic partnership to integrate OpenAI's most advanced models across Novo Nordisk — from drug discovery through commercial — and upskill the global workforce on AI.
b.well integration lets users connect data across providers, systems and insurers — turning fragmented records into a unified view and grounding AI answers in actual medical history.
Settlement ends the compounded GLP-1 dispute: Hims will stop scaling compounded versions and offer branded Novo Nordisk weight-loss drugs directly through its platform.
Commentary on 'Moltbook,' a Reddit-style platform where autonomous agents post and debate. Raises governance questions for healthcare agents acting on patient data.
Up to $1B over five years to build a multidisciplinary AI lab focused on the hardest problems in drug discovery — infrastructure, foundation models and joint research.
OpenAI publishes HealthBench, evaluating LLMs against physician-graded clinical scenarios — a step toward measurable clinical readiness.
Collaboration on Denmark's Gefion supercomputer using NVIDIA BioNeMo, NeMo and Omniverse to build agents that predict cellular response and design drug-like molecules.
Partnership applies QuantHealth's clinical-AI simulation to Sanofi's pipeline — modelling trial outcomes in silico to de-risk study design and accelerate enrolment.